Cerrahpaşa Medical Journal
ORIGINAL ARTICLE

Predictive Effect of EPS Results on Prostate Cancer Detection in Patients with High PSA Values

1.

Department of Urology, Private Genesis Hospital, Diyarbakır, Turkey

Cerrahpasa Med J 2022; 46: 126-128
DOI: 10.54614/cjm.2022.21106
Keywords : EPS, PSA, prostate cancer
Read: 64 Downloads: 20 Published: 23 May 2022

Background: The aim of this study was to evaluate prostate cancer detection rates with the expressed prostatic secretion test to avoid unnecessary prostate biopsy procedures and increase prostate-specific antigen reliability in patients with high prostate-specific antigen values.

Methods: Ninety-three expressed prostatic secretion-positive and 97 expressed prostatic secretion-negative patients with serum prostate-specific antigen levels of 2.5 ng/mL were included in this retrospective study. The diagnostic evaluation included a detailed history and physical examination, digital rectal examination, urinalysis, urine culture, and the expressed prostatic secretion test. Transrectal ultrasonography was used both to measure the prostate volume and obtain 12-core prostate biopsies.

Results: In our study, the mean age of the 190 patients was 62.59 ± 8.47 years. The mean prostate-specific antigen value of the patients was 5.25 ± 1.7 ng/mL, the mean International Prostatism Symptom Score was 11.8 ± 7, and the mean prostatic volume was 47.5 ± 20 mL. Prostate cancer was detected in 10 patients in the expressed prostatic secretion-positive group and 20 patients in the expressed prostatic secretion-negative group (P = .034).

Conclusion: In the expressed prostatic secretion-negative group, the rate of prostate cancer detection was statistically significantly higher.

Cite this article as: Yariş M. Predictive effect of EPS results on prostate cancer detection in patients with high PSA values. Cerrahpaşa Med J. 2022;46(2):126-128.

Files
EISSN 2687-1904